Blockade of the Programmed Death-1 Pathway Restores Sarcoidosis CD4+ T-Cell Proliferative Capacity
Nicole Braun(Office of Infectious Diseases), Wonder P. Drake(Vanderbilt University Medical Center), Lindsay J. Celada(Vanderbilt University), David S. Wilkes(Indiana University School of Medicine), Ryszard Dworski(Vanderbilt University), Guzel Shaginurova(Vanderbilt University), Jan C. Grutters(St. Antonius Ziekenhuis), Jose D. Herazo‐Maya(University of South Florida), Pierre P. Massion(Vanderbilt University), Joyce E. Johnson(Vanderbilt University), James R. Sheller(Vanderbilt University), Naftali Kaminski(Yale University), Vasiliy V. Polosukhin, Daniel A. Culver(Cleveland Clinic), Susamma Abraham(Cleveland Clinic), Carla M. Sevin(Vanderbilt University), Kyra Oswald‐Richter(Vanderbilt University)
Cited by 139
Related Papers
Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2020|1k
The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak
|Nature Medicine|2007|820
Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation
|American Journal of Respiratory and Critical Care Medicine|2013|686